| Class | H1 receptor antagonist |
|---|---|
| Chemistry |
Phenothiazine |
| Routes of administration |
Oral, IV, IM, s/c |
| Absorption |
Well absorbed, but only 25% bioavailability due to vigorous first pass metabolism |
| Solubility |
pKa 9.1, freely soluble in water |
| Distribution |
VOD=30L/kg, 93% protein bound (mainly to albumin) |
| Metabolism |
Undergoes extensive hepatic metabolism, mainly by CYP 2D6 |
| Elimination |
Clearance is almost completely hepatic; only some minimal amount is eliminated by the kidneys |
| Time course of action |
Half-life 12-15 hours; duration of effect is 8-12 hours |
| Target receptor |
All phenothiazines are competitive antagonists of multiple receptors: |
| Mechanism of action |
Multiple mechanisms of action: |
| Clinical effects |
#NAME? |
| Literature reference |
TGA document |
| CICM details of understanding | Level 3 |
| Mentioned around Deranged Physiology | |
| Related SAQs |
|